All In Biotech

Free tool

FAERS Monitor: Zestoretic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019888 or its brand name (Zestoretic, Hydrochlorothiazide, Lisinopril). Reports on generic versions are filed under their own applications.

Reports

10,267

Serious

6,201

60% of reports

Hospitalization

3,320

Death reported

596

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea692
  • fatigue684
  • diarrhoea618
  • drug ineffective577
  • pain505
  • dizziness498
  • dyspnoea444
  • headache438
  • asthenia372
  • vomiting357
  • cough354
  • arthralgia341
  • fall334
  • hypertension326
  • malaise314

Reports by year received

View as table
YearReports
2004174
2005178
2006210
2007230
2008312
2009501
2010786
2011771
2012726
2013175
2014440
2015833
2016581
2017430
2018553
2019474
2020530
2021449
2022417
2023410
2024355
2025440
2026292

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,892 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypertensionSignal3263.22.8482
coughSignal3542.62.3348
fallSignal3342.11.9183
dizzinessSignal4982.01.9272
astheniaSignal3722.01.8196
diarrhoea6182.01.8300
fatigue6841.81.7252
nausea6921.81.7251
pain5051.71.5144
arthralgia3411.71.595
dyspnoea4441.61.5104
vomiting3571.61.472
malaise3141.51.347
headache4381.41.358
drug ineffective5770.90.87

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.